XIAMEN SINOPEG BIOTECH CO. LTD.

SINOPEG is dedicated to drug delivery systems and related medical device business, focusing on the research, development, production and sales of high-end drug delivery carriers/auxiliary materials/APIs, medical materials, including but not limited to polyethylene glycol derivatives, lipid products, blood sugar control drug modifiers, block copolymers, ADC/ProTAC linkers, biodegradable polymers, exosomes, viral-like particles, as well as providing CDMO and solution services. SINOPEG has a technical team led by overseas returned doctors and foreign experts, established good cooperation relations with well-known universities and research institutes in China, such as Xiamen University, Fudan University and the Institute of Chemistry of Chinese Academy of Sciences. SINOPEG is proud collaborator with a number of well-known universities, research institutes, and pharmaceutical and biotech companies around the globe. SINOPEG’s vision is to be an science company, providing innovative materials and technology to partner with our customers on current treatment improvement and new therapeutics development for improved patient treatment quality and better human health. SINOPEG partners with our customers and collaborators to create value through:. SINOPEG is able to customize a wide range of drug delivery system accessory products from mg to kg, and our products can meet the specific requirements of customers. SINOPEG's vision is be an science company, providing innovative materi-als and technology to partner with our customers on current treatment improvement and new therapeutics development for improved patient treatment quality and better human health. We are delighted to announce that SINOPEG will be participating in the LNP Formulation & Process Development Summit 2024 Agreement, scheduled to take place on April 29, 2024, in Boston, USA.